Search

Your search keyword '"Wentworth, D"' showing total 270 results

Search Constraints

Start Over You searched for: Author "Wentworth, D" Remove constraint Author: "Wentworth, D"
270 results on '"Wentworth, D"'

Search Results

1. Trends in mortality in people with HIV from 1999 to 2020: a multi-cohort collaboration

2. Risk for non-AIDS-defining and AIDS-defining cancer of early versus delayed initiation of antiretroviral therapy

3. Increased Indoleamine-2,3-Dioxygenase Activity Is Associated With Poor Clinical Outcome in Adults Hospitalized With Influenza in the INSIGHT FLU003Plus Study

4. Risk for non-AIDS-defining and AIDS-defining cancer of early versus delayed initiation of antiretroviral therapy: A multinational prospective cohort study

10. Anti-influenza hyperimmune intravenous immunoglobulin for adults with influenza A or B infection (FLU-IVIG): a double-blind, randomised, placebo-controlled trial

11. Where do all the subtypes go? : Temporal dynamics of H8-H12 influenza A viruses in waterfowl

13. Using clinical research networks to assess severity of an emerging influenza pandemic

14. Increased indoleamine-2,3-dioxygenase activity is associated with poor clinical outcome in adults hospitalized with influenza in the INSIGHT FLU003Plus study

16. Development and validation of a risk score for chronic kidney disease in HIV infection using prospective cohort data from the D:A:D study

17. Contribution of genetic background, traditional risk factors, and HIV-related factors to coronary artery disease events in HIV-positive persons

18. Predictors of bacterial pneumonia in Evaluation of Subcutaneous Interleukin-2 in a Randomized International Trial (ESPRIT)

19. Cumulative and current exposure to potentially nephrotoxic antiretrovirals and development of chronic kidney disease in HIV-positive individuals with a normal baseline estimated glomerular filtration rate: a prospective international cohort study

20. Opérationnalisation de la randomisation d’un essai vaccinal en population générale africaine : exemple de l’essai PREVAC (« Partnership for Research on Ebola Vaccination »)

23. Circulating microRNAs in Sera Correlate with Soluble Biomarkers of Immune Activation but Do Not Predict Mortality in ART Treated Individuals with HIV-1 Infection: A Case Control Study

24. Non-AIDS defining cancers in the D:A:D Study--time trends and predictors of survival: a cohort study

25. Development of a definition for rapid progression (RP) of renal function in HIV-positive persons:the D:A:D study

26. Increased risk of cardiovascular disease (CVD) with age in HIV-positive men: a comparison of the D:A:D CVD risk equation and general population CVD risk equations

27. Development and validation of a risk score for chronic kidney disease in HIV infection using prospective cohort data from the D:A:D study

28. Development and Validation of a Risk Score for Chronic Kidney Disease in HIV Infection Using Prospective Cohort Data from the D:A:D Study

29. Circulating microRNAs in sera correlate with soluble biomarkers of immune activation but do not predict mortality in ART treated individuals with HIV-1 infection: A case control study

30. Development and Validation of a Risk Score for Chronic Kidney Disease in HIV Infection Using Prospective Cohort Data from the D:A:D Study

31. Development and validation of a risk score for chronic kidney disease in HIV infection using prospective cohort data from the D:A:D study.

32. Predictors of bacterial pneumonia in the Evaluation of Subcutaneous Interleukin-2 in a Randomized International Trial (ESPRIT)

34. Effects of intermittent IL-2 alone or with peri-cycle antiretroviral therapy in early HIV infection: The STALWART study

35. Predicting the risk of cardiovascular disease in HIV-infected patients: the data collection on adverse effects of anti-HIV drugs study

36. High prevalence of the metabolic syndrome in HIV-infected patients: impact of different definitions of the metabolic syndrome

37. Adjudicated morbidity and mortality outcomes by age among individuals with HIV infection on suppressive antiretroviral therapy

38. Standardized metadata for human pathogen/vector genomic sequences

39. Interleukin-2 therapy in patients with HIV infection

40. Interleukin-2 therapy in patients with HIV infection.: Interleukin-2 for patients with HIV

41. HIV-induced immunodeficiency and mortality from AIDS-defining and non-AIDS-defining malignancies

42. Changes over time in risk factors for cardiovascular disease and use of lipid-lowering drugs in HIV-infected individuals and impact on myocardial infarction

43. Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D:A:D study: a multi-cohort collaboration

46. Innate immune response of human alveolar macrophages during influenza A infection

47. Interleukin-2 therapy in patients with HIV infection

Catalog

Books, media, physical & digital resources